Bacterial Strain Cryopreservation Methods: Glycerol Preservation, Ultra-Low Temperature Storage, and Recovery Quality Control
Bacterial Strain Cryopreservation Methods: Glycerol Preservation, Ultra-Low Temperature Storage, and Recovery Quality Control
Bacterial strain cryopreservation is used to preserve strain viability, genetic stability, and phenotypic characteristics over the long term. Common methods include glycerol cryopreservation, compound cryoprotectant-based cryopreservation, ultra-low temperature storage at -80°C, liquid nitrogen storage, and freeze-drying. The actual method should be selected according to strain tolerance, storage duration, recovery frequency, and downstream experimental requirements.
Keywords: bacterial cryopreservation; strain preservation; glycerol stock; bacterial cryopreservation solution; -80°C storage; compound cryoprotectant; strain recovery; cryopreservation quality control
1 Basic Principles of Bacterial Strain Cryopreservation
1.1 Purpose of Cryopreservation
(1) Maintaining strain viability
The core purpose of cryopreservation is to reduce bacterial metabolic activity so that strains remain recoverable over an extended period. Compared with continuous subculture, cryopreservation can reduce mutation accumulation, phenotypic drift, and contamination risk.
(2) Maintaining genetic stability
Experimental strains, engineered strains, reference strains, and quality control strains should be passaged as few times as possible. Establishing a master seed bank and a working seed bank can reduce genetic changes caused by repeated recovery and serial subculture.
(3) Maintaining experimental traceability
Bacterial cryopreservation records should include strain number, source, passage number, culture conditions, cryopreservation date, cryoprotectant system, and operator information. Unclear labeling or missing records can directly affect the reproducibility of subsequent experiments.
1.2 Factors to Confirm Before Cryopreservation
(1) Strain type
Different bacteria vary markedly in their tolerance to low temperature, osmotic stress, and freezing injury. Escherichia coli, Bacillus subtilis, lactic acid bacteria, anaerobes, actinomycetes, and clinical isolates may require different cryoprotectants and recovery conditions.
(2) Culture status
Cultures selected for cryopreservation should generally be healthy, uncontaminated, and phenotypically stable. Over-aged cultures may have reduced viability, whereas cultures at very early growth stages may have insufficient biomass; both can affect recovery success.
(3) Cryoprotectant system
Glycerol, DMSO, sucrose, trehalose, gelatin, BSA, skim milk, or medium components can be used as cryoprotectants or as part of compound cryoprotectant systems. Cryoprotectants reduce ice crystal damage, osmotic shock, and cell membrane disruption.
(4) Storage temperature
Short-term storage, long-term cryopreservation, and seed bank management have different temperature requirements. Ultra-low temperature storage at -80°C is a common strategy, while liquid nitrogen is suitable for longer-term storage or strains requiring higher stability.
Table 1 Comparison of commonly used bacterial strain preservation methods
Preservation Method | Applicable Duration | Main Use | Main Advantages | Main Limitations |
Short-term slant preservation | Weeks to months | Temporary strain maintenance and short-term turnover | Simple operation and convenient recovery | Susceptible to passage drift and contamination |
Short-term storage at 4°C | Short term | Temporary storage of cultured plates or slants | Suitable for short-term backup | Not suitable for long-term storage |
Storage at -20°C | Short-term or transitional storage | Temporary storage of some tolerant strains | Low equipment requirement | More obvious ice crystal damage; not recommended for long-term strain preservation |
-80°C glycerol cryopreservation | Long term | Routine bacterial strain bank | Broad applicability and relatively high recovery rate | Requires stable ultra-low temperature equipment |
Liquid nitrogen storage | Long term | Valuable strains and low-temperature-sensitive strains | High storage stability | High equipment and management requirements |
Freeze-drying preservation | Long term | Reference strains, transportation, and long-term preservation | Convenient transportation at room temperature or low temperature | High process requirements; some strains are not tolerant |
2 Glycerol Cryopreservation
2.1 Method Positioning
Glycerol cryopreservation is one of the most commonly used bacterial cryopreservation methods and is applicable to most routine experimental strains. Glycerol reduces ice crystal formation and osmotic shock. When combined with -80°C storage, it enables long-term strain preservation.
(1) Applicable strains
Common laboratory strains, engineered strains, general environmental isolates, and most aerobic bacteria can be prioritized for glycerol cryopreservation. For special strains, the cryoprotectant system should be adjusted according to strain characteristics, recommendations from strain repositories, or pilot experimental results.
(2) Cryoprotectant grade
Glycerol used for strain cryopreservation should preferably be of stable quality, such as molecular biology grade, anhydrous grade, ACS grade, AR grade, microbiology grade, or cell culture-compatible grade. Analytical standards or standard solutions are more suitable for quantitative analysis and are not preferred as routine cryoprotectants.
(3) Cryovial management
Cryovials should be sterile, resistant to low temperature, and well sealed. Each cryovial should be recovered only once to avoid reduced viability and contamination risk caused by repeated freeze-thaw cycles.
2.2 Key Control Points for Glycerol Cryopreservation
(1) Bacterial status
Before cryopreservation, the culture should be confirmed to be uncontaminated, morphologically consistent, and in good growth condition. For engineered strains requiring plasmid or expression system maintenance, selection pressure and target construct stability should also be confirmed.
(2) Mixing method
The bacterial suspension and glycerol cryoprotectant should be thoroughly mixed to avoid local inconsistency in cryoprotectant concentration. The mixing process should minimize aerosol generation and contamination risk, and room-temperature exposure should be shortened as much as possible.
(3) Cooling process
Routine bacterial glycerol stocks can usually be placed directly at -80°C for storage. For low-temperature-sensitive or difficult-to-recover strains, controlled-rate cooling or dedicated freezing containers may be considered to reduce injury caused by rapid cooling.
(4) Recovery method
During recovery, the cryovial should remain at room temperature for as short a time as possible. After sampling, the vial should either be immediately returned to low-temperature storage or discarded if thawed, to avoid repeated freeze-thaw cycles.
3 Compound Cryoprotectant-Based Cryopreservation
3.1 Significance of Compound Cryoprotectants
A single glycerol system is not suitable for all bacteria. Lactic acid bacteria, anaerobes, some environmental bacteria, and difficult-to-culture strains may require compound cryoprotectants to improve post-thaw survival and recovery stability.
(1) DMSO
DMSO can be used as a component of some cryoprotective systems, but it has certain toxicity to cells and microorganisms. Exposure time, working concentration, and removal after recovery all need optimization. For routine bacterial cryopreservation, glycerol is usually preferred, while DMSO is more suitable as an alternative cryoprotectant for special strains or optimized systems.
(2) Sugar-based cryoprotectants
Sucrose and trehalose can reduce cryopreservation injury by stabilizing membrane structures and protein conformations. They are often used in freeze-drying or compound cryopreservation systems. For lactic acid bacteria, probiotics, and some freeze-thaw-sensitive strains, sugar-based cryoprotectants can be combined with glycerol, protein protectants, or culture medium.
(3) Protein and colloidal protectants
Gelatin, BSA, skim milk, and related materials can provide colloidal protection and stabilize the microenvironment. They are suitable for freeze-drying systems or strains sensitive to freeze-thaw damage. Sterility, batch consistency, and compatibility with downstream detection methods should be considered when using these materials.
3.2 Applicable Scenarios
(1) Lactic acid bacteria and probiotics
Lactic acid bacteria are relatively sensitive to freezing and drying and often require sugars, skim milk, or compound cryoprotectants to improve post-storage viability. After recovery, colony morphology, acid production capacity, and growth curves should be evaluated.
(2) Anaerobes
For anaerobic bacteria, oxygen exposure must be controlled in addition to cryoprotection. The cryopreservation system, aliquoting, recovery, and culture process should maintain appropriate low-oxygen or anaerobic conditions as much as possible.
(3) Actinomycetes and filamentous bacteria
Some actinomycetes or filamentous bacteria can be cryopreserved according to their spore, mycelial, or dispersed cell state. If obvious bacterial aggregation occurs, uniformity of cell quantity within cryovials should be considered.
Table 2 Key points for selecting bacterial cryoprotectants
Cryoprotectant Type | Representative Materials | Main Function | Applicable Scenarios | Notes |
Polyols | Glycerol, DMSO | Reduce ice crystal formation and osmotic injury | Routine bacteria, engineered strains, special cryoprotective systems | DMSO should not be used as the default option for all bacteria |
Sugars | Sucrose, trehalose | Stabilize membrane structures and protein conformations | Lactic acid bacteria, freeze-drying protection, sensitive strains | Concentration needs optimization to avoid excessive osmotic pressure |
Protein/colloid protectants | Gelatin, BSA, skim milk | Provide colloidal protection and reduce freeze-thaw injury | Sensitive strains and freeze-drying systems | Batch variation and sterility should be considered |
Medium systems | TSB, SOC, R2A, etc. | Provide an adaptive recovery environment | Routine strains or strains with special nutritional requirements | Should match strain culture characteristics |
Buffer systems | PBS, phosphate buffer | Control pH and ionic environment | Dilution, washing, or compound cryoprotective systems | Limited nutritional value; not suitable as a protective solution for all strains |
4 Ultra-Low Temperature and Liquid Nitrogen Storage
4.1 Ultra-Low Temperature Storage at -80°C
Storage at -80°C is suitable for most laboratory strain banks and is the most common management strategy for long-term bacterial cryopreservation. The key factors are not only temperature, but also aliquoting strategy, cryopreservation records, and equipment stability.
(1) Master bank and working bank
The master bank is used for long-term storage and should be opened and recovered as rarely as possible. The working bank is used for routine experimental recovery. Separate management of the master bank and working bank can reduce loss of valuable strains.
(2) Multiple aliquots
Multiple cryovials should be established for the same strain to avoid repeated sampling from a single vial. One vial should be used for each recovery to reduce contamination and freeze-thaw injury.
(3) Temperature fluctuation control
Cryoboxes should be placed in fixed positions to reduce frequent door opening and prolonged exposure. Temperature fluctuations accelerate loss of viability, especially for sensitive strains.
4.2 Liquid Nitrogen Storage
Liquid nitrogen storage is suitable for strains requiring long storage duration, high value, or difficult recovery. Compared with -80°C storage, liquid nitrogen further reduces metabolic activity and injury risk, but requires more stringent management.
(1) Applicable strains
Valuable reference strains, preserved engineered strains, slow-growing strains, and strains with unstable recovery rates can be considered for liquid nitrogen storage.
(2) Safety management
Liquid nitrogen storage requires compatible cryovials and storage racks to avoid tube rupture, label detachment, and loss of cryopreservation information.
(3) Recovery verification
Liquid nitrogen storage does not eliminate the need for quality control. Long-term preserved strains should still be periodically verified for recovery rate, purity, and key phenotypes.
5 Freeze-Drying Preservation
5.1 Method Positioning
Freeze-drying is suitable for some reference strains, industrial strains, and strains requiring transportation. After freeze-drying, strains can be stored long term at low moisture content, making transportation and distribution more convenient.
(1) Applicable strains
Spore-forming bacteria, some desiccation-tolerant bacteria, and process-optimized reference strains are more suitable for freeze-drying. For freeze-drying-sensitive strains, -80°C or liquid nitrogen storage should be prioritized.
(2) Cryoprotectant system
Freeze-drying protectants often contain sugars, proteins, or compound protective systems to reduce structural damage during freezing, drying, and rehydration. Trehalose, sucrose, gelatin, BSA, and skim milk-related materials are commonly used for optimization of such systems.
(3) Rehydration conditions
During recovery of freeze-dried strains, rehydration medium, temperature, and standing time can affect recovery performance. After rehydration, the strain should be transferred to a suitable culture system as soon as possible to reduce stress duration.
5.2 Limitations of Freeze-Drying Preservation
(1) Strong process dependency
Freeze-drying performance is affected by pre-freezing, sublimation, protectants, bacterial status, and residual moisture. An unoptimized freeze-drying process may lead to a marked decrease in recovery rate.
(2) Not suitable for all strains
Some Gram-negative bacteria, non-spore-forming bacteria, or desiccation-sensitive strains may show low survival after freeze-drying and should be validated through pilot experiments.
(3) High quality control requirements
After freeze-drying preservation, purity, viability, phenotype, and key functions still need to be verified, especially for industrial strains and reference strains.
Table 3 Selection of cryopreservation strategies for different bacterial strain types
Strain Type | Recommended Preservation Method | Protective System Selection | Quality Control Focus |
Routine laboratory strains | -80°C glycerol cryopreservation | Glycerol + compatible medium | Recovery rate, colony morphology, contamination check |
Engineered strains | -80°C master/working bank | Glycerol + selective culture background | Plasmid stability, target gene or expression function |
Lactic acid bacteria | -80°C storage or freeze-drying | Glycerol/sugars/skim milk compound system | Viable count, acid production capacity, growth curve |
Anaerobes | -80°C storage or liquid nitrogen | Compound cryoprotectant + low-oxygen handling | Anaerobic recovery, purity, and growth viability |
Spore-forming bacteria | -80°C storage or freeze-drying | Glycerol system or freeze-drying protectants | Spore formation status and recovery consistency |
Valuable reference strains | -80°C + liquid nitrogen backup | Validated protective system | Periodic recovery, identity confirmation, phenotypic stability |
Difficult-to-culture strains | Liquid nitrogen or optimized cryopreservation | Compound cryoprotectants | Recovery rate and reproducibility of culture conditions |
6 Recovery and Quality Control
6.1 Recovery Principles
The goal of recovering cryopreserved strains is to rapidly restore growth while avoiding contamination and selection bias. Recovery conditions should be consistent with, or as close as possible to, the pre-cryopreservation culture conditions.
(1) Minimize freeze-thaw cycles
Cryovials should be processed as soon as possible after removal from low temperature. Thawed cryovials are not recommended to be returned to the long-term storage bank.
(2) Select an appropriate recovery medium
The recovery medium should match the characteristics of the strain. Routine bacteria can be recovered using systems such as TSB, nutrient broth, or SOC. Nutrient-poor or environmental isolates may be recovered using media such as R2A, while anaerobes may require compatible systems such as thioglycollate medium.
(3) Observe colony morphology
After recovery, colony size, color, margin, transparency, and growth rate should be observed. Abnormal colonies should be assessed for contamination, mutation, or selection bias caused by recovery stress.
6.2 Cryopreservation Quality Control
(1) Purity check
After recovery, purity should be confirmed by plate streaking, microscopic observation, or molecular identification when necessary. Mixed cultures or contamination can affect downstream experimental results.
(2) Identity confirmation
Key strains should be confirmed by strain-specific PCR, sequencing, mass spectrometry identification, or phenotypic testing, especially after long-term storage or multiple transfers.
(3) Functional verification
Engineered strains, enzyme-producing strains, fermentation strains, and standard quality control strains should be verified for key functions such as antibiotic resistance, product formation, enzyme activity, plasmid retention, or standard reaction characteristics.
(4) Distinction from RNA sample preservation
If cryopreserved strains will later be used for transcript-level analysis, “viable strain preservation” and “RNA sample preservation” should be distinguished. Bacterial cryopreservation solution is used to maintain strain recoverability, whereas non-freezing bacterial RNA preservation solution is used to stabilize bacterial RNA and is suitable for subsequent RNA extraction, RT-qPCR, or transcriptome analysis. It cannot replace viable bacterial cryoprotectants.
(5) Record management
Cryopreservation records should include strain number, cryopreservation date, cryoprotectant system, medium, passage number, storage location, and recovery results. Strain bank management determines long-term traceability more than a single cryopreservation operation.
Table 4 Quality control points for bacterial cryopreservation and recovery
Step | Key Control Point | Possible Problem | Recommended Treatment |
Pre-cryopreservation culture | Select a healthy culture | Aged cells and low viability | Use cultures in good growth condition |
Cryoprotectant mixing | Consistent concentration and thorough mixing | Insufficient protection or osmotic injury | Standardize formula and mixing method |
Aliquoting and labeling | Multiple aliquots and clear labels | Label detachment or sample confusion | Use cryogenic labels and electronic records |
Storage temperature | Stable -80°C or liquid nitrogen | Temperature fluctuation and repeated freeze-thaw | Reduce door opening and handling time |
Recovery culture | Match culture conditions | Slow recovery or selection bias | Use appropriate medium and recovery conditions |
RNA sample preservation | Distinguish RNA preservation solution from viable cryopreservation solution | Misuse of RNA preservation solution as a cryoprotectant | Select preservation system according to downstream detection purpose |
Purity check | Streaking and morphology observation | Contamination or mixed culture | Recover from a backup vial |
Functional verification | Phenotypic or molecular validation | Plasmid loss or functional decline | Trace back to the master bank or rebuild the strain bank |
7 Common Problems and Troubleshooting
7.1 No Growth After Recovery
Recovery failure may result from poor bacterial status before cryopreservation, unsuitable cryoprotectants, temperature fluctuation, excessive storage duration, or mismatched recovery conditions. Other cryovials from the same batch should be checked first, and cryopreservation records and culture conditions should be reviewed.
7.2 Smaller Colonies or Slow Growth After Recovery
Smaller colonies may be associated with freeze-thaw stress, unsuitable culture medium, or reduced strain fitness. A recovery culture step can be performed first, followed by evaluation of whether the normal phenotype is restored.
7.3 Plasmid Loss After Recovery of Engineered Strains
Plasmid loss may be related to insufficient selection pressure during passaging, instability of the strain before cryopreservation, or improper selection pressure after recovery. Before establishing an engineered strain bank, the plasmid and target insert should be confirmed. After recovery, antibiotic resistance or molecular validation should be performed.
7.4 Precipitation or Phase Separation in Cryovials
Precipitation or phase separation may result from medium components, insufficient mixing of cryoprotectants, or differences during freezing. If recovery rate is abnormal, the strain bank should be rebuilt and the cryoprotectant system optimized.
7.5 Large Recovery Differences Among Cryovials of the Same Strain
Differences may result from insufficient mixing of the bacterial suspension before aliquoting, inconsistent cell quantity among cryovials, or temperature fluctuations at storage locations. During strain bank establishment, suspension mixing, aliquot volume, and cryovial location management should be standardized.
8 Related Reagent and Material Selection
Table 5 Reagent and material selection for bacterial strain cryopreservation and recovery
Cat. No. | Product Name | Grade/Purity | Application Module | Application Positioning |
Ready-to-Use Bacterial Preservation Solution | BioReagent,sterile | Ready-to-use cryopreservation system | Used for standardized bacterial strain cryopreservation, reducing batch-to-batch variation caused by self-prepared protective solutions | |
Bacterial Preservation Solution | BioReagent,sterile | Ready-to-use cryopreservation system | Used for bacterial strain aliquoting, low-temperature storage, and working strain bank establishment | |
Non-freezing Bacteria RNA Preservation Solution | BioReagent,Suitable for molecular biology,ready-to-use | RNA sample preservation/molecular detection support | Used for stabilizing bacterial RNA samples, suitable for subsequent RNA extraction, RT-qPCR, or transcriptome analysis; not used for long-term viable bacterial cryopreservation and recovery | |
Glycerol | Suitable for molecular biology, ≥99% | Glycerol cryoprotectant | Used for preparing routine bacterial glycerol stocks, suitable for preservation of molecular biology laboratory strains | |
Glycerol | Anhydrous Grade, UltraBio™, Suitable for molecular biology, ≥99.5%(GC) | High-quality glycerol cryoprotectant | Used for strain cryopreservation systems requiring stricter control of water content, impurities, and molecular biology background | |
Glycerol | ACS, ≥99.5% | Glycerol cryoprotectant | Used for preparing routine laboratory glycerol-based cryopreservation systems | |
Glycerol | ≥99.5%(GC) | Glycerol cryoprotectant | Used for bacterial cryopreservation systems requiring higher-purity glycerol | |
Glycerol | AR, ≥99% | Glycerol cryoprotectant | Used for preparing general bacterial strain cryopreservation solutions | |
Glycerol | for cell culture, suitable for insect cell culture, ≥99%(GC) | Biological experiment-grade cryoprotectant | Can be used in cryoprotective systems requiring higher biocompatibility | |
Dimethyl sulfoxide(DMSO) | sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7% | Special cryoprotectant | Can be used as an alternative low-temperature protective component for special strains or compound cryoprotectant systems | |
Dimethyl sulfoxide(DMSO) | Suitable for molecular biology, ≥99.9% | Special cryoprotectant | Used for optimization of DMSO-based protective systems requiring molecular biology grade materials | |
Dimethyl sulfoxide(DMSO) | sterile-filtered, USP, suitable for hybridoma, Ph.Eur., BioPerformance Certified | Sterile DMSO cryoprotectant | Used for special cryopreservation systems requiring sterile, pharmacopeial-grade, or highly consistent DMSO | |
Dimethyl sulfoxide(DMSO) | Ultra pure, ≥99.9% | Special cryoprotectant | Used for low-impurity DMSO protective systems or method optimization | |
Dimethyl sulfoxide(DMSO) | Anhydrous Grade, ≥99.9% | Special cryoprotectant | Used for DMSO systems requiring strict water content control | |
Sucrose | Moligand™, Suitable for molecular biology, ≥99.5%(HPLC) | Sugar-based cryoprotectant | Used for compound cryoprotectants, freeze-drying protection systems, and protection of sensitive strains | |
Sucrose | Moligand™, Ultra pure, ≥99.9%, RNase,DNase Free | High-purity sugar protectant | Used for strain protection systems sensitive to nuclease background or sample protection before molecular detection | |
Sucrose | Moligand™, for cell culture, suitable for insect cell culture, ≥99.5% | Biological experiment-grade sugar protectant | Used in compound cryoprotectant systems to help reduce freeze-thaw injury | |
Sucrose | Moligand™, ACS | Sugar protectant | Used for preparation of routine compound cryopreservation solutions or freeze-drying protective systems | |
D-(+)-Trehalose dihydrate | for cell culture, suitable for insect cell culture, ≥99% | Sugar protectant | Used in compound protective systems for lactic acid bacteria, probiotics, or freeze-drying-sensitive strains | |
D-(+)-Trehalose dihydrate | ≥99%, from cassava starch | Sugar protectant | Used for freeze-drying protection, membrane stabilization, and optimization of cryopreservation conditions for sensitive strains | |
D-(+)-Trehalose dihydrate | ≥99% | Sugar protectant | Used for compound cryoprotectant systems and screening of cryopreservation/freeze-drying protection conditions | |
Gelatin | Suitable for microbiology, gel strength ~250 g Bloom | Colloidal protectant | Used in microbial freeze-drying or compound protective systems to reduce freeze-thaw and drying injury | |
Gelatin | Reagent Grade | Colloidal protectant | Used for general compound protective systems or exploration of freeze-drying protection systems | |
Low endotoxin gelatin from porcine skin | gel strength240-360(Bloom)<10 EU/gEndotoxin | Low-endotoxin colloidal protectant | Used for development of protective systems requiring low endotoxin background | |
Bovine Serum Albumin(BSA) | Suitable for molecular biology,Component V | Protein protectant | Used in compound cryopreservation or freeze-drying protective systems to stabilize the bacterial microenvironment | |
Bovine Serum Albumin(BSA) | Low Endotoxin, for cell culture, ≥98%, chromatographically purified, New Zealand origin, pH 7 | Low-endotoxin protein protectant | Used in strain protective systems requiring controlled endotoxin and impurity levels | |
Bovine Serum Albumin(BSA) | sterile-filtered, for cell culture, Low Endotoxin, 10% in DPBS, fatty acid free | Sterile protein protectant | Used for sterile compound protective systems or optimization of sensitive strain cryopreservation systems | |
Bovine Serum Albumin(BSA) | Low Endotoxin, Protease Free, ≥98%, Lyophilized | Low-endotoxin protein protectant | Used in freeze-drying protection, compound cryopreservation, and protective systems requiring controlled protein background | |
Phosphate Buffered Saline with 3% Non-Fat Milk, pH 7.4 |
| Skim milk/buffer protective system | Can be used in milk protein-containing compound protective systems, freeze-drying condition exploration, or sensitive strain protection | |
PBS (pH 7.4, Sterile) | BioReagent,Low Endotoxin,sterile-filtered,for cell culture | Buffer/dilution system | Used for bacterial washing, cryoprotectant preparation, and sample dilution before cryopreservation | |
PBS, DNase&RNase Free | sterile-filtered, BioReagent, DNase, RNase free, ready-to-use, for cell culture, 1× | Molecular experiment-compatible buffer | Used for bacterial processing requiring reduced nuclease background or sample treatment before molecular detection | |
PhosphateBuffered Saline(PBS)1X concentrate | 1X,sterile,pH7.2-7.4 | Buffer/dilution system | Used for routine bacterial washing, dilution, and compound cryoprotectant preparation | |
PhosphateBuffered Saline(PBS)20X concentrate | sterile | Concentrated buffer | Used for on-demand PBS preparation to support cryoprotectant formulation or pre-recovery processing | |
Trypticase Soy Broth | BioReagent, Suitable for microbiology | Recovery medium | Used for recovery, expansion, and viability restoration of various cryopreserved bacteria | |
SOC Broth | BioReagent, Suitable for microbiology | Engineered strain recovery medium | Used for recovery after E. coli transformation, recovery of engineered strains, and nutrient-rich recovery culture | |
General Broth Medium | BioReagent, Suitable for microbiology | Routine recovery medium | Used for general bacterial recovery and short-term expansion | |
R2A Agar | BioReagent, Suitable for microbiology | Low-nutrient recovery/environmental bacterial culture | Used for recovery observation of environmental isolates, low-nutrient-requiring strains, or slow-growing strains | |
BBL Agar Medium Base | BioReagent, Suitable for microbiology | Plate culture/purity check | Used for post-recovery streaking, colony morphology observation, and purity testing | |
Thioglycollate Medium | BioReagent, Suitable for microbiology | Anaerobic/microaerophilic recovery | Used for recovery and activity restoration of anaerobes or strains requiring low-oxygen conditions | |
King's B Medium | BioReagent, Suitable for microbiology | Specific strain recovery/phenotype observation | Used for culture and phenotypic observation of some Pseudomonas and related strains | |
Eosin Methylene Blue Agar (EMB) | BioReagent, Suitable for microbiology | Selective and differential culture | Used for post-recovery identification of Gram-negative enteric bacteria and contamination screening | |
Mannitol Salt Agar | BioReagent, Suitable for microbiology | Selective and differential culture | Used for post-recovery identification and purity observation of salt-tolerant staphylococcal strains | |
Xylose Lysine Deoxycholate Agar (XLD) | BioReagent, Suitable for microbiology | Selective and differential culture | Used for selective culture and contamination screening of some intestinal bacteria after recovery | |
Violet Red Bile Glucose Agar |
| Selective and differential culture | Used for selective culture and quality control of Enterobacteriaceae-related strains after recovery | |
Bismuth Sulfite Agar Medium |
| Selective and differential culture | Used for specific Salmonella-related detection or selective culture scenarios | |
Levine Eosin-Methylene Blue Agar Medium |
| Selective and differential culture | Used for isolation and identification of intestinal Gram-negative bacteria after recovery | |
Sabouraud Dextrose Agar | BioReagent, Suitable for microbiology | Fungal/yeast recovery support | Used for recovery of yeast or fungal microorganisms; not used as the primary medium for bacterial cryopreservation | |
YPD Broth | BioReagent, Suitable for microbiology | Yeast recovery support | Used for recovery and expansion of cryopreserved yeast strains; not used as the primary medium for bacterial cryopreservation | |
YPD Broth with Agar (premixed powder) | BioReagent, Suitable for microbiology | Yeast plate recovery support | Used for plate culture and purity observation after recovery of cryopreserved yeast strains |
9 Frequently Asked Questions
9.1 What is the most commonly used method for bacterial cryopreservation?
Most routine bacteria can be preserved in a glycerol-based protective system at -80°C. This method has broad applicability and is suitable for laboratory strain banks, engineered strains, and routine experimental strains.
9.2 Can glycerol stocks be repeatedly frozen and thawed?
Repeated freeze-thaw cycles are not recommended. They reduce bacterial viability and increase contamination risk. Multiple aliquots should be prepared, and one cryovial should be used for each recovery to avoid repeated sampling from the same vial.
9.3 Can bacteria be stored long term at -20°C?
In general, -20°C is not recommended for long-term strain preservation. Ice crystal injury and temperature fluctuations are more pronounced at -20°C. It is suitable for short-term or transitional storage, but not for long-term preservation of important strains.
9.4 What should be considered when cryopreserving engineered strains?
Before cryopreservation, plasmid, resistance marker, and target construct stability should be confirmed. After recovery, antibiotic resistance, target fragment, or expression function should be verified according to experimental purpose, and passage number should be controlled.
9.5 Why are compound cryoprotectants commonly used for lactic acid bacteria?
Lactic acid bacteria are sensitive to freezing, thawing, and drying damage, and a single glycerol system may sometimes provide insufficient protection. Sugars, skim milk, or protein-based protectants can improve survival rate and recovery stability.
Bacterial cryopreservation methods should be selected according to strain characteristics, storage duration, and recovery requirements. Routine strains can preferentially be preserved using -80°C glycerol cryopreservation, sensitive strains can be optimized with compound cryoprotectants, and valuable or long-term preserved strains can be backed up with liquid nitrogen or freeze-drying. Stable strain bank management, clear records, and recovery quality control are essential for ensuring long-term strain usability and reproducible experimental results.
